FGFR1 is an important prognostic factor in oral leukoplakia and tongue squamous cell carcinoma

被引:1
|
作者
Mariz, Bruno Augusto Linhares Almeida [1 ,5 ]
de Sa, Raisa Sales [1 ]
Araujo, Anna Luiza Damaceno [1 ]
Fernandes, Carla Isabelly Rodrigues [1 ]
Mariano, Fernanda Viviane [2 ]
Santos-Silva, Alan Roger [1 ]
Lopes, Marcio Ajudarte [1 ]
Vargas, Pablo Agustin [1 ]
de Almeida, Oslei Paes [1 ]
Kowalski, Luiz Paulo [3 ,4 ]
Jorge, Jacks [1 ]
机构
[1] Univ Campinas UNICAMP, Piracicaba Dent Sch, Oral Diag Dept, Piracicaba, Brazil
[2] Univ Campinas UNICAMP, Fac Med Sci, Dept Pathol, Campinas, Brazil
[3] A C Camargo Canc Ctr, Dept Head & Neck Surg & Otorhinolaryngol, Sao Paulo, Brazil
[4] Univ Sao Paulo, Med Sch, Head & Neck Surg Dept, Sao Paulo, Brazil
[5] Univ Estadual Campinas, Piracicaba Dental Sch, Oral Diag Dept, OralPathol Lab, 901, Ave Limeira, Areao, BR-13414903 Sao Paulo, Brazil
关键词
AKT; FGFR1; immunohistochemistry; oral cancer; oral leukoplakia; HEAD; AMPLIFICATION; DYSPLASIA;
D O I
10.1111/jop.13398
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Fibroblast growth factor receptor 1 is a potential prognostic factor for tongue squamous cell carcinoma and is associated with oral epithelial dysplasia grade in oral leukoplakia.Methods: Thirty cases of tongue squamous cell carcinoma and 30 cases of oral leukoplakia were analyzed. Fibroblast growth factor receptor 1 and phosphorylated Akt protein expression were analyzed by immunohistochemistry and quantified using a digital algorithm. Fibroblast growth factor receptor 1 gene amplification was analyzed by fluorescent in situ hybridization in the tongue squamous cell carcinoma cases.Results: Clinical appearance and dysplasia grade were correlated with oral leukoplakia malignant transformation. Oral leukoplakia cases presenting high fibroblast growth factor receptor 1 expression showed a higher risk of malignant transformation (p = 0.016, HR: 7.3, 95% CI: 1.4-37.4). Phosphorylated Akt showed faint to no expression in oral leukoplakia, which did not correlate with dysplasia grade or malignant transformation. High expression of fibroblast growth factor receptor 1 and phosohorylated Akt were associated with poor overall survival and disease-free survival in tongue squamous cell carcinoma, although only fibroblast growth factor receptor 1 expression was significantly associated with poor overall survival (p = 0.024; HR: 4.9, 95% CI: 1.2-19.9). Cases presenting double fibroblast growth factor receptor 1/phosphorylated Akt overexpression (n = 8) showed markedly impaired overall survival (p = 0.020; HR: 6.4, 95% CI: 1.3-31.1) and disease-free survival (p = 0.001, HR: 13.0, 95% CI: 3.0-55.7). Fibroblast growth factor receptor 1 amplification was observed in 16.6% of tongue squamous cell carcinoma cases, being correlated with vascular and neural invasion (p = 0.001 and 0.017, respectively), but not with fibroblast growth factor receptor 1 protein expression, overall survival, or disease-free survival.Conclusion: Fibroblast growth factor receptor 1 protein expression is an important prognostic factor in oral leukoplakia and tongue squamous cell carcinoma.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 50 条
  • [41] Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma
    Sridharan, Gokul
    Ramani, Pratibha
    Patankar, Sangeeta
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2017, 13 (03) : 556 - 561
  • [42] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Menon, R.
    Goltz, D.
    Scheble, V.
    Kirsten, R.
    Vogel, W.
    Boehm, D.
    Schroeck, A.
    Perner, S.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S195 - S195
  • [43] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Scheble, V.
    Goltz, D.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Schroeck, A.
    Perner, S.
    MODERN PATHOLOGY, 2012, 25 : 477A - 477A
  • [44] Rationale for treatment of metastatic squamous cell carcinoma of the lung using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Schroeck, A.
    Scheble, V.
    Kirsten, R.
    Menon, R.
    Goltz, D.
    Boehm, D.
    Vogel, W.
    Perner, S.
    VIRCHOWS ARCHIV, 2012, 461 : S51 - S51
  • [45] Concomitant leukoplakia in patients with oral squamous cell carcinoma
    Schepman, KP
    van der Meij, EH
    Smeele, LE
    van der Waal, I
    ORAL DISEASES, 1999, 5 (03) : 206 - 209
  • [46] Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using FGFR1 Inhibitors
    Goeke, F.
    Franzen, A.
    Mennon, R.
    Scheble, V.
    Goltz, D.
    Kirsten, R.
    Boehm, D.
    Vogel, W.
    Schroeck, A.
    Perner, S.
    LABORATORY INVESTIGATION, 2012, 92 : 477A - 477A
  • [47] Midkine expression in oral squamous cell carcinoma and leukoplakia
    Jham, Bruno Correia
    Costa, Nadia Lago
    Silva, Janine Mayra
    de Miranda, Alessandra Castro
    Oliveira, Jose Carlos
    Silva, Tarcilia Aparecida
    Batista, Aline Carvalho
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2012, 41 (01) : 21 - 26
  • [48] The Prevalence of FGFR1 Amplification in Lung Squamous Cell Carcinoma as Revealed by FISH Analysis
    Wang, L.
    Wang, K.
    Islamdoust, N.
    Hasanovic, A.
    Ladanyi, M.
    Jhanwar, S. C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 711 - 711
  • [49] Prognostic significance of tumor budding thresholds in oral tongue squamous cell carcinoma
    Mascitti, Marco
    Togni, Lucrezia
    Caponio, Vito Carlo Alberto
    Zhurakivska, Khrystyna
    Lo Muzio, Lorenzo
    Rubini, Corrado
    Santarelli, Andrea
    Troiano, Giuseppe
    ORAL DISEASES, 2023, 29 (05) : 1947 - 1958
  • [50] Prognostic Value of Anteroposterior Extension in Oral Tongue and Floor Squamous Cell Carcinoma
    Contro, Giacomo
    Sordi, Alessandra
    Taboni, Stefano
    Citterio, Marco
    Ruaro, Alessandra
    De Lucia, Giulia
    Pinacoli, Aurora
    Carobbio, Andrea Luigi Camillo
    Montalto, Nausica
    Ramacciotti, Giulia
    Grammatica, Alberto
    Marioni, Gino
    Zanoletti, Elisabetta
    Maroldi, Roberto
    Piazza, Cesare
    Mattavelli, Davide
    Nicolai, Piero
    Ferrari, Marco
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2024, 150 (02) : 142 - 150